PhRMA booked $456 million of revenue in 2017. Photo: Bob Herman/Axios

PhRMA, the pharmaceutical industry's main lobbying group, considerably bolstered its political and financial position during President Trump's first year in office, new federal tax filings show.

The bottom line: PhRMA directed tens of millions of dollars toward conservative think tanks, political groups of all stripes and patient advocates with the hope of convincing the public that the industry isn't "getting away with murder," as Trump put it, and that others are to blame for the country's drug pricing maze.

By the numbers: The world's largest drug companies are members of PhRMA, and they paid a lot more in membership dues last year.

  • PhRMA's total revenue in 2017 was $456 million, up 68% from 2016.
  • Membership dues rose 62% year over year to $396 million.

Where did that money go? Pretty much everywhere.

  • Federal and state lobbying increased 126% in 2017. Two large law firms, Covington & Burling and Arnold & Porter, combined to collect $8.6 million alone from PhRMA.
  • Tens of millions in grants were funneled to patient advocacy groups that often stay silent about rising drug prices. Some of the largest PhRMA-funded patient groups were the Addiction Policy Forum, the Leukemia & Lymphoma Society and the AIDS Institute.
  • PhRMA's advertising budget multiplied by almost 10 times. Ad agency Young & Rubicam and PR firm Porter Novelli cumulatively were paid $17 million.
  • Seven PhRMA executives made at least $1 million in 2017. PhRMA CEO Stephen Ubl made the most with almost $3.1 million, up 9% from his pay in 2016.

Politically motivated spending: PhRMA gave millions to political groups representing both parties and to conservative-leaning think tanks that embrace free-market policy ideas. 

  • The biggest recipient was America First Policies, a "dark money" conservative nonprofit that promotes Trump's agenda, which received $2.5 million. 
  • Other recipients of at least $1 million from PhRMA were the American Action Network and the National Republican Redistricting Trust — both on the political right — as well as Center Forward, a bipartisan political action committee pushing centrist reforms.

Yes, but: Other political beneficiaries included both the Republican ($325,000) and Democratic ($305,000) Governors Associations, as well as both candidates for Virginia governor last year (each received $20,000).

  • PhRMA also gave small political contributions to tons of state candidates across the nation — presumably ensuring friendly faces will be located in plenty of places.
  • Conservative ideology is obviously much more favorable to PhRMA, as it resists federal intervention in the marketplace. But the organization has clearly decided contributing to both parties is a worthwhile expenditure.

Be smart: PhRMA has always used its financial resources to influence state and federal policies that protect its members' profitable businesses, and the group arguably has more money to play with than ever.

  • But that didn't prevent PhRMA from being blindsided earlier this year when Congress shifted some Medicare costs to drug companies.

Go deeper

The many divisions over Trump's methane rollback

Illustration: Rebecca Zisser/Axios

EPA's decision to cut regulation of methane is laying bare an oil-and-gas industry divide and setting the stage for political battles this fall and beyond.

Why it matters: Methane is an extremely powerful greenhouse gas and the industry is a key emissions source.

Kushner says Trump didn't promote false Kamala Harris birtherism theory

White House senior adviser Jared Kushner told "CBS This Morning" on Friday that he does not believe President Trump promoted a baseless claim that Sen. Kamala Harris is ineligible to be vice president.

Driving the news: During a press briefing on Thursday, Trump did not question the veracity of a Newsweek op-ed that inaccurately claimed Harris may be ineligible for the office due to her parents' naturalization status at the time of her birth. Harris is an American citizen and was born in Oakland, Calif.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 9 a.m. ET: 20,952,811 — Total deaths: 760,235— Total recoveries: 13,015,397Map.
  2. U.S.: Total confirmed cases as of 9 a.m. ET: 5,254,878 — Total deaths: 167,253 — Total recoveries: 1,774,648 — Total tests: 64,831,306Map.
  3. Health: The pandemic's toll on mental health — The kids who are most at risk.
  4. Business: How small businesses got stiffed — Unemployment starts moving in the right direction.
  5. Politics: Biden signals fall strategy with new ads.
  6. 🎧 Podcast: Economic data turns unreliable.